Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Piccinini

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Medchemcomm|August 16, 2018
4-Hydroxy-<i>N</i>-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascadeAgnese C Pippione, Antonella Federico, Alex Ducime, et al.
Medchemcomm|August 16, 2018
<i>N</i>-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIKAgnese C Pippione, Stefano Sainas, Antonella Federico, et al.
Journal of Medicinal Chemistry|June 18, 2025
Fluorescent Isostere (<i>Fluostere</i>) of the Carboxylate: Design of <i>h</i>DHODH Fluorescent Inhibitors as Proof of ConceptStefano Sainas, Elena Martino, Claudio Garino, et al.
Journal of Neurochemistry|February 4, 2009
Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type ABarbara Buccinnà, Marco Piccinini, Alessandro Prinetti, et al.
European Journal of Medicinal Chemistry|February 26, 2017
Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffoldsStefano Sainas, Agnese C Pippione, Marta Giorgis, et al.
European Journal of Medicinal Chemistry|March 19, 2026
Structure-based design of new pyrazole inhibitors targeting Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH)Agnese C Pippione, Noemi Villella, Federico Fornaseri, et al.
Journal of Medicinal Chemistry|January 30, 2019
Correction to Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase InhibitorsStefano Sainas, Agnese C Pippione, Elisa Lupino, et al.
Journal of Medicinal Chemistry|June 26, 2018
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase InhibitorsStefano Sainas, Agnese C Pippione, Elisa Lupino, et al.
European Journal of Medicinal Chemistry|May 12, 2026
Targeting dihydroorotate dehydrogenase (hDHODH) beyond the barrier: discovery of MEDS700 as blood-brain barrier permeable hDHODH inhibitorStefano Sainas, Chiara Vigato, Paola Circosta, et al.
Journal of Medicinal Chemistry|April 12, 2021
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-<i>a</i>]pyridine Scaffold: SAR of the Biphenyl MoietyStefano Sainas, Marta Giorgis, Paola Circosta, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Medchemcomm|August 16, 2018
4-Hydroxy-<i>N</i>-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascadeAgnese C Pippione, Antonella Federico, Alex Ducime, et al.
Medchemcomm|August 16, 2018
<i>N</i>-Acetyl-3-aminopyrazoles block the non-canonical NF-kB cascade by selectively inhibiting NIKAgnese C Pippione, Stefano Sainas, Antonella Federico, et al.
Journal of Medicinal Chemistry|June 18, 2025
Fluorescent Isostere (<i>Fluostere</i>) of the Carboxylate: Design of <i>h</i>DHODH Fluorescent Inhibitors as Proof of ConceptStefano Sainas, Elena Martino, Claudio Garino, et al.
Journal of Neurochemistry|February 4, 2009
Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type ABarbara Buccinnà, Marco Piccinini, Alessandro Prinetti, et al.
European Journal of Medicinal Chemistry|February 26, 2017
Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffoldsStefano Sainas, Agnese C Pippione, Marta Giorgis, et al.
European Journal of Medicinal Chemistry|March 19, 2026
Structure-based design of new pyrazole inhibitors targeting Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH)Agnese C Pippione, Noemi Villella, Federico Fornaseri, et al.
Journal of Medicinal Chemistry|January 30, 2019
Correction to Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase InhibitorsStefano Sainas, Agnese C Pippione, Elisa Lupino, et al.
Journal of Medicinal Chemistry|June 26, 2018
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase InhibitorsStefano Sainas, Agnese C Pippione, Elisa Lupino, et al.
European Journal of Medicinal Chemistry|May 12, 2026
Targeting dihydroorotate dehydrogenase (hDHODH) beyond the barrier: discovery of MEDS700 as blood-brain barrier permeable hDHODH inhibitorStefano Sainas, Chiara Vigato, Paola Circosta, et al.
Journal of Medicinal Chemistry|April 12, 2021
Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-<i>a</i>]pyridine Scaffold: SAR of the Biphenyl MoietyStefano Sainas, Marta Giorgis, Paola Circosta, et al.
Pageof 5